DexCom
Stock Forecast, Prediction & Price Target
DexCom Financial Estimates
DexCom Revenue Estimates
DexCom EBITDA Estimates
DexCom Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $2.44B N/A | $2.90B 18.84% | $3.62B 24.48% | Avg: $5.15B Low: $5.02B High: $5.24B avg. 42.22% | Avg: $6.04B Low: $5.91B High: $6.17B avg. 17.39% | Avg: $6.95B Low: $6.80B High: $7.10B avg. 15.01% | Avg: $7.75B Low: $7.58B High: $7.91B avg. 11.42% |
Net Income
% change YoY
| $154.7M N/A | $341.2M 120.55% | $541.5M 58.70% | Avg: $908.49M Low: $731.86M High: $1.17B avg. 67.77% | Avg: $1.13B Low: $1.03B High: $1.44B avg. 25.19% | Avg: $1.46B Low: $1.42B High: $1.50B avg. 28.81% | Avg: $1.65B Low: $1.61B High: $1.70B avg. 13.11% |
EBITDA
% change YoY
| $277.4M N/A | $416.9M 50.28% | $916.7M 119.88% | Avg: $844.62M Low: $823.30M High: $859.38M avg. -7.86% | Avg: $991.54M Low: $970.35M High: $1.01B avg. 17.39% | Avg: $1.14B Low: $1.11B High: $1.16B avg. 15.01% | Avg: $1.27B Low: $1.24B High: $1.29B avg. 11.42% |
EPS
% change YoY
| $0.4 N/A | $0.88 120% | $1.44 63.63% | Avg: $2.21 Low: $1.72 High: $2.76 avg. 53.50% | Avg: $2.73 Low: $2.43 High: $3.39 avg. 23.53% | Avg: $3.44 Low: $3.35 High: $3.54 avg. 26.09% | Avg: $3.9 Low: $3.79 High: $4 avg. 13.11% |
Operating Expenses
% change YoY
| $1.41B N/A | $1.49B 5.45% | $1.69B 13.35% | Avg: $1.72B Low: $1.68B High: $1.75B avg. 1.96% | Avg: $2.02B Low: $1.98B High: $2.06B avg. 17.39% | Avg: $2.32B Low: $2.27B High: $2.37B avg. 15.01% | Avg: $2.59B Low: $2.53B High: $2.64B avg. 11.42% |
FAQ
What is DexCom stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 33.72% in 2025-2028.
We have gathered data from 15 analysts. Their low estimate is 731.86M, average is 908.49M and high is 1.17B.
What is DexCom stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.51% in 2025-2028.
We have gathered data from 19 analysts. Their low revenue estimate is $5.02B, average is $5.15B and high is $5.24B.
What is DexCom stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 29.06% in 2025-2028.
We have gathered data from 15 analysts. Their low earnings per share estimate is $1.72, average is $2.21 and high is $2.76.
What is the best performing analyst?
In the last twelve months analysts have been covering DexCom stock. The most successful analyst is Mathew Blackman.